30 Publications (Page 2 of 2)
2000
Intravenous diltiazem and CYP3A-mediated metabolism.
Masica, A LAzie, N EBrater, D CHall, Stephen D and Jones, David R
British journal of clinical pharmacology, vol. 50, (no. 3), pp. 273-6, 2000/Sep. | Journal Article
 
In vivo effects of interleukin-10 on human cytochrome P450 activity.
Gorski, J. CHall, Stephen DBecker, PAffrime, M BCutler, D L and Haehner-Daniels, B
Clinical pharmacology and therapeutics, vol. 67, (no. 1), pp. 32-43, 2000/Jan. | Journal Article
1999
Biotransformation of alprazolam by members of the human cytochrome P4503A subfamily.
Gorski, J. CJones, David RHamman, M AWrighton, S A and Hall, Stephen D
Xenobiotica; the fate of foreign compounds in biological systems. , vol. 29, (no. 9), pp. 931-44, 1999/Sep. | Journal Article
 
Molecular and physical mechanisms of first-pass extraction.
Hall, Stephen DThummel, K EWatkins, PaulLown, K SBenet, Leslie ZPaine, M FMayo, R RTurgeon, D. KBailey, D GFontana, R J and Wrighton, S A
Drug metabolism and disposition: the biological fate of chemicals. , vol. 27, (no. 2), pp. 161-6, 1999/Feb. | Journal Article
1997
Contribution of human CYP3A subfamily members to the 6-hydroxylation of chlorzoxazone.
Gorski, J. CJones, David RWrighton, S A and Hall, Stephen D
Xenobiotica; the fate of foreign compounds in biological systems, vol. 27, (no. 3), pp. 243-56, 1997/Mar. | Journal Article